VWF and platelet-type von Willebrand disease: The addition of VWF replacement or ddAVP/desmopressin was thought to confer more risk than benefit because no laboratory defect in VWF (qualitative or quantitative) was found to support a diagnosis of von Willebrand disease (VWD).